Form 13-F position report

AVALO THERAPEUTICS INC COM PAR

Reported by PERCEPTIVE ADVISORS LLC

AVTX CUSIP 05338F306 Manager CIK 0001224962

Reported 139,667 shares, unchanged from the prior quarter.

Reported value 154.7%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 0.05% This manager · Q3 2025
Shares 139,667 Quarter-end amount reported
Reported value $1,775,168 Fair value at quarter end
Consecutive quarters held 3 Through Q3 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-03-31 4165200
2025-06-30 696938
2025-09-30 1775168
2025-12-31 2536353
2026-03-31 2085228
2026-06-30 4062144

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for AVALO THERAPEUTICS INC COM PAR held by PERCEPTIVE ADVISORS LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Added 219,813 +80,146 (57.4%) 0.06% $4,062,144 2026-08-14
Q1 2026 Unchanged 139,667 0 (0.0%) 0.04% $2,085,228 2026-05-15
Q4 2025 Unchanged 139,667 0 (0.0%) 0.05% $2,536,353 2026-02-17
Q3 2025 Unchanged 139,667 0 (0.0%) 0.05% $1,775,168 2025-11-14
Q2 2025 Reduced 139,667 -380,333 (-73.1%) 0.03% $696,938 2025-08-14
Q1 2025 New 520,000 +520,000 (0.0%) 0.15% $4,165,200 2025-05-15

Who else reported the position

68 managers reported AVALO THERAPEUTICS INC COM PAR for Q3 2025.

Managers reporting AVALO THERAPEUTICS INC COM PAR in Q3 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BVF INC IL Added 1,355,256 +327,207 0.7% $17,225,304 5 qtrs
ORBIMED ADVISORS LLC Added 1,349,300 +382,300 0.4% $17,149,603 5 qtrs
Nantahala Capital Management LLC Added 1,235,000 +240,000 0.55% $15,696,850 3 qtrs
Point72 Asset Management L P New 1,053,983 +1,053,983 0.02% $13,396,124 1 qtr
Affinity Asset Advisors LLC Added 1,006,217 +398,345 1.11% $12,789,018 7 qtrs
Caligan Partners LP New 833,333 +833,333 1.39% $10,591,662 1 qtr
Balyasny Asset Management LLC New 817,436 +817,436 0.01% $10,389,612 1 qtr
SILVERARC CAPITAL MANAGEMENT LLC New 720,922 +720,922 1.24% $9,162,919 1 qtr
VANGUARD GROUP INC Added 692,637 +525,696 < 0.01% $8,803,417 6 qtrs
RA CAPITAL MANAGEMENT L P Reduced 662,968 -270,005 0.1% $8,426,323 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2025
Filed
November 14, 2025
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
139,667
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.